Investor News
February 5, 2009 - Change of Adviser
Cyprotex PLC
(“Cyprotex“ or “the Company“)
The Directors of Cyprotex wish to announce that Noble & Company Limited has been appointed as Nominated Adviser and Broker to the Company with immediate effect.
Cyprotex PLC
Dr Anthony Baxter, CEO
Mark Warburton, Company Secretary
Tel: +44 (0)1625 505 100
ir@cyprotex.com
www.cyprotex.com
Noble & Company Limited
John Llewellyn-Lloyd
Sam Reynolds
Tel: +44 (0)20 7763 2200
noble@noblegp.com
www.noblegp.com
Media Enquires
Pelham PR
Simon Miller
Tel: +44 (0)20 3178 4419
simon.miller@pelhampr.com
www.pelhampr.com
